WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium

American Journal of Pathology

Volumn 150, Issue 1, 1997, Pages 167-175

  Lukas, Jason ^a   Groshen, Susan ^a,b   Saffari, Bahman ^a   Niu, Ning ^a   Reles, Angela ^a   Wen, Wen Hsiang ^a   Felix, Juan ^a   Jones, Lovell A ^c   Hall, Frederick L ^a,b   Press, Michael F ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; DNA; PROTEIN P21; PROTEIN P53;

AMINO ACID SUBSTITUTION; ARTICLE; BREAST CARCINOMA; CODON; CONTROLLED STUDY; DNA SEQUENCE; ENDOMETRIUM CARCINOMA; EXON; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEIC ACID BASE SUBSTITUTION; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; SINGLE STRAND CONFORMATION POLYMORPHISM;

BREAST NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENDOMETRIAL NEOPLASMS; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 15444358265     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. WAf1/Cip1 is a universal inhibitor of cyclin kinases, Nature 1993, 366:701-704
2. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993, 75:805-816
3. EI-Diery WS, Tokino Tr Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825
4. Sdil/ciP1/WAF1 EMBO J 1994, 14:555-563
5. EI-Diery WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW, Vogelstein B: WAF1/Cip1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994, 54:1169-1174
6. Zhang, H, Hannon GJ, Beach D: p21 -containing cyclin kinases exist in both active and inactive states. Genes Dev 1994, 8:1750-1758
7. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D: Induction of WAF1/Cip1 by a p53 independent pathway, Cancer Res 1994, 54:3391-3395
8. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T: Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms, Proc Natl Acad Sci USA 1989, 86:2766-2770
9. Michaud J, Brody LC, Steel G, Fontaine G, Martin LS, Valle D, Mitchell G: Strand-separating conformational polymorphism analysis: efficacy of detection of point mutations in the human ornithine δ-aminotransferase gene, Genomics 1992, 13:389-394
10. Press MF, Nousek-Goebl NA, King WJ, Herbst AL, Greene GL: Immunohistochemical assessment of estrogen receptor distribution in the human endometrium throughout the menstrual cycle, Lab Invest 1984, 51:495-502
11. Xiong Y, Zhang H, Beach D: D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 1992, 71:505-514
12. Zhang H, Xiong Y, Beach D: Proliferating cell nuclear antigen and p21 are components of multiple cell cycles kinase complexes, Mol Biol Cell 1993, 4:897-906
13. Waga S, Hannon GJ, Beach D, Stillman B: The p21 inhibitor of cyctin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994, 369:574-578
14. Li Y, Jenkins CW, Nichols MA, Xiong Y: Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 1994, 9:2261-2268
15. Cip1/WAF1 undergo normal development, but are defective in G1 checkpoint control, Cell 1995, 82:675-684
16. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB: Correlation of terminal cell cycle arrest of skeletal muscle with induction of p27 by MyoD. Science 1995, 267:1018-1021
17. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olson EN, Harper JW, Elledge SJ: p53-independent expression of p21 in muscle and other terminally differentiating cells. Science 1995, 267:1024-1027
18. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994, 78:59-66
19. Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res 1995, 55:1211-1214
20. Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 1995, 9:639-649
21. cip1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 1995, 9:650-662
22. Shiohara M, EI-Diery WS, Wada M, Nakamaki T, Takeuchi S, Yang R, Chen D-L, Vogelstein B, Koeffler HP: Absence of WAF1 mutations in a variety of human malignancies, Blood 1994, 84:3781-3784
23. Chedid M, Michieli P, Lengel C, Huppi K, Givol D: A single nucleotide at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1. Oncogene 1994, 9:3021-3024
24. Lewin B: Genes V. Oxford, Oxford University Press, 1994, p 150
25. Taioli E, Crofts F, Trachman J, Demopoulos R, Tonioli P, Garte SJ: A specific African-American CYP1A1 polymorphism is associated with adenocarcinoma of the lung. Cancer Res 1995, 55:472-473
26. Nazar-Stewart V, Motulsky AG, Eaton DL, White E, Hornung SK, Leng Z-T, Stapleton P, Weiss NS; The glutathione S-tranferase μ, polymorphism as a marker for susceptibility to lung carcinoma, Cancer Res 1993, 53:2313-2318
27. WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 1995, 55:2910-2919
28. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang X-F: Transforming growth factor-β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism, Proc Natl Acad Sci USA 1995, 92:5545-5549